Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783641089> ?p ?o ?g. }
- W2783641089 endingPage "299.e3" @default.
- W2783641089 startingPage "292" @default.
- W2783641089 abstract "While the impact of very low concentrations of low–density lipoprotein cholesterol (LDL-C) on cardiovascular prevention is very reassuring, it is intriguing to know what effect these extremely low LDL-C concentrations have on lipid homoeostasis. The evidence supporting the safety of extremely low LDL levels comes from genetic studies and clinical drug trials. Individuals with lifelong low LDL levels due to mutations in genes associated with increased LDL-LDL receptor (LDLR) activity reveal no safety issues. Patients achieving extremely low LDL levels in the IMPROVE-IT and FOURIER, and the PROFICIO and ODYSSEY programs seem not to have an increased prevalence of adverse effects. The main concern regarding extremely low LDL-C plasma concentrations is the adequacy of the supply of cholesterol, and other molecules, to peripheral tissues. However, LDL proteomic and kinetic studies reaffirm that LDL is the final product of endogenous lipoprotein metabolism. Four of 5 LDL particles are cleared through the LDL-LDLR pathway in the liver. Given that mammalian cells have no enzymatic systems to degrade cholesterol, the LDL-LDLR pathway is the main mechanism for removal of cholesterol from the body. Our focus, therefore, is to review, from a physiological perspective, why such extremely low LDL-C concentrations do not appear to be detrimental. We suggest that extremely low LDL-C levels due to increased LDLR activity may be a surrogate of adequate LDL-LDLR pathway function." @default.
- W2783641089 created "2018-01-26" @default.
- W2783641089 creator A5003907607 @default.
- W2783641089 creator A5016235258 @default.
- W2783641089 creator A5020529537 @default.
- W2783641089 creator A5024327523 @default.
- W2783641089 creator A5037440569 @default.
- W2783641089 creator A5040190129 @default.
- W2783641089 creator A5046300531 @default.
- W2783641089 creator A5048724654 @default.
- W2783641089 creator A5057374991 @default.
- W2783641089 creator A5060752196 @default.
- W2783641089 creator A5070287647 @default.
- W2783641089 creator A5071468133 @default.
- W2783641089 creator A5076504309 @default.
- W2783641089 creator A5082478161 @default.
- W2783641089 creator A5083733947 @default.
- W2783641089 creator A5085251638 @default.
- W2783641089 date "2018-03-01" @default.
- W2783641089 modified "2023-10-07" @default.
- W2783641089 title "Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis" @default.
- W2783641089 cites W1520609538 @default.
- W2783641089 cites W1546258268 @default.
- W2783641089 cites W1574689408 @default.
- W2783641089 cites W1874026010 @default.
- W2783641089 cites W1922389415 @default.
- W2783641089 cites W1964590451 @default.
- W2783641089 cites W1976643033 @default.
- W2783641089 cites W1977084774 @default.
- W2783641089 cites W1995191011 @default.
- W2783641089 cites W1998346348 @default.
- W2783641089 cites W1999277192 @default.
- W2783641089 cites W2000789033 @default.
- W2783641089 cites W2001328643 @default.
- W2783641089 cites W2009503588 @default.
- W2783641089 cites W2011018921 @default.
- W2783641089 cites W2011030761 @default.
- W2783641089 cites W2011946223 @default.
- W2783641089 cites W2017113887 @default.
- W2783641089 cites W2022101016 @default.
- W2783641089 cites W2024059969 @default.
- W2783641089 cites W2029638583 @default.
- W2783641089 cites W2038054558 @default.
- W2783641089 cites W2039788401 @default.
- W2783641089 cites W2049444075 @default.
- W2783641089 cites W2052601297 @default.
- W2783641089 cites W2054455620 @default.
- W2783641089 cites W2063972305 @default.
- W2783641089 cites W2074149397 @default.
- W2783641089 cites W2075528397 @default.
- W2783641089 cites W2080545893 @default.
- W2783641089 cites W2085159827 @default.
- W2783641089 cites W2086502603 @default.
- W2783641089 cites W2092688668 @default.
- W2783641089 cites W2096137537 @default.
- W2783641089 cites W2097454735 @default.
- W2783641089 cites W2097510503 @default.
- W2783641089 cites W2098990121 @default.
- W2783641089 cites W2107358135 @default.
- W2783641089 cites W2115169717 @default.
- W2783641089 cites W2115598881 @default.
- W2783641089 cites W2116717181 @default.
- W2783641089 cites W2117842413 @default.
- W2783641089 cites W2118524679 @default.
- W2783641089 cites W2123248870 @default.
- W2783641089 cites W2129809363 @default.
- W2783641089 cites W2131577329 @default.
- W2783641089 cites W2133184701 @default.
- W2783641089 cites W2139168645 @default.
- W2783641089 cites W2146228563 @default.
- W2783641089 cites W2146707618 @default.
- W2783641089 cites W2151602225 @default.
- W2783641089 cites W2152175870 @default.
- W2783641089 cites W2158092179 @default.
- W2783641089 cites W2159449551 @default.
- W2783641089 cites W2160727503 @default.
- W2783641089 cites W2163488353 @default.
- W2783641089 cites W2164089346 @default.
- W2783641089 cites W2165791625 @default.
- W2783641089 cites W2166910397 @default.
- W2783641089 cites W2169433762 @default.
- W2783641089 cites W2170420840 @default.
- W2783641089 cites W2171596868 @default.
- W2783641089 cites W2179575662 @default.
- W2783641089 cites W2184909359 @default.
- W2783641089 cites W2200285648 @default.
- W2783641089 cites W2210694332 @default.
- W2783641089 cites W2234444148 @default.
- W2783641089 cites W2250472293 @default.
- W2783641089 cites W2304056429 @default.
- W2783641089 cites W2305216237 @default.
- W2783641089 cites W2343162767 @default.
- W2783641089 cites W2407075011 @default.
- W2783641089 cites W2413701858 @default.
- W2783641089 cites W2417423427 @default.
- W2783641089 cites W2465758073 @default.
- W2783641089 cites W2487422893 @default.
- W2783641089 cites W2495887823 @default.